Fund Holdings — Camber Capital Management LP

Total Portfolio Value
$2.56M
Total Bought
$527.8K
Total Sold
$508.7K
Net Transaction
+$19.1K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
PFIZER INC(PFE)05,000,000+5,000,00001335.19%+133
HUMANA INC(HUM)200,000650,000+450,000631656.45%+102
THE CIGNA GROUP(CI)0150,000+150,0000411.62%+41
CVS HEALTH CORP(CVS)1,500,0003,000,000+1,500,000941355.27%+40
ALKERMES PLC(ALKS)200,0001,500,000+1,300,0006431.69%+38
BIOMARIN PHARMACEUTICAL INC(BMRN)0450,000+450,0000301.16%+30
CONCENTRA GROUP HOLDINGS PAR(CON)1,975,0003,500,000+1,525,00044692.71%+25
SAREPTA THERAPEUTICS INC(SRPT)775,0001,000,000+225,000971224.76%+25
IONIS PHARMACEUTICALS INC(IONS)0625,000+625,0000220.85%+22
ANAPTYSBIO INC01,250,000+1,250,0000170.65%+17
PTC THERAPEUTICS INC(PTCT)3,500,0003,200,000-300,0001301445.65%+15
10X GENOMICS INC(TXG)01,000,000+1,000,0000140.56%+14
JAZZ PHARMACEUTICALS PLC(JAZZ)1,150,0001,150,00001281425.54%+14
VIATRIS INC(VTRS)15,000,00015,000,00001741877.30%+13
MERUS N V0250,000+250,0000110.41%+11
STRUCTURE THERAPEUTICS INC0300,000+300,000080.32%+8
ASCENDIS PHARMA A/S(ASND)700,000800,000+100,0001051104.31%+6
EVOLENT HEALTH INC(EVH)1,400,0004,000,000+2,600,00040451.76%+5
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)441,000441,000022240.93%+2
THERAVANCE BIOPHARMA INC(TBPH)1,000,0001,000,0000890.37%+1
GENMAB A/S(GMAB)50,00050,0000110.04%-0
MEDPACE HLDGS INC(MEDP)125,000125,000042421.62%-0
INOGEN INC(INGN)2,000,0002,000,000019180.72%-1
HERBALIFE LTD(HLF)3,000,0003,000,000022200.79%-1
QIAGEN NV(QGEN)1,500,0001,500,000068672.61%-2
THE BEAUTY HEALTH COMPANY(SKIN)1,500,0000-1,500,00020—-2
ORASURE TECHNOLOGIES INC(OSUR)4,250,0004,250,000018150.60%-3
ZIMVIE INC2,725,0002,725,000043381.49%-5
BROOKDALE SR LIVING INC(BKD)250,000250,000023170.67%-6
DENALI THERAPEUTICS INC(DNLI)2,000,0002,250,000+250,00058461.79%-12
BICYCLE THERAPEUTICS PLC915,0000-915,000210—-21
BROOKDALE SR LIVING INC(BKD)13,935,00013,935,000095702.74%-25
MEDTRONIC PLC(MDT)2,750,0002,750,00002482208.59%-28
UNIVERSAL HLTH SVCS INC(UHS)125,0000-125,000290—-29
GSK PLC(GSK)3,000,0002,500,000-500,000123853.31%-38
GLOBUS MED INC(GMED)2,150,0001,225,000-925,0001541013.96%-52
MYRIAD GENETICS INC(MYGN)3,950,0003,100,000-850,000108431.66%-66
SELECT MED HLDGS CORP2,125,0000-2,125,000740—-74
ZIMMER BIOMET HOLDINGS INC(ZBH)2,500,0001,605,000-895,0002701706.63%-100
BAXTER INTL INC6,500,0004,625,000-1,875,0002471355.28%-112
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q4 2024 | TickerTrail